A Phase 1 Study to Determine the Single-dose Pharmacodynamics, Pharmacokinetics, and Safety and Tolerability of Remimazolam Following Oral Administration With and Without Alcohol in Healthy Female Subjects
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Remimazolam (Primary) ; Alcohol
- Indications Anaesthesia; Sedation
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors PAION
- 05 Aug 2020 Status changed to discontinued.
- 05 Aug 2020 Results from two trials (NCT04113564, NCT04113343) evaluate the bioavailability and pharmacokinetic/pharmacodynamic (PK/PD) profile of oral remimazolam, alone and in combination with alcohol, and to investigate the potential for misuse of oral administration of remimazolam published in the Drugs in R and D
- 04 Oct 2019 New trial record